Skip to content
S7137Senate2021-2022 SessionSame asA8080

Expand Kidney Care Centers

Official title

“Relates to the provision of end stage renal disease services”

Sponsor Michael GianarisSD-12+1 co-sponsorAffects Health
Status
In Assembly Committee
Health
Impact
5/10
Moderate
Passage
0%

Bill progress

Step 5 of 7

In Assembly · Health

What's happening

This bill allows ambulatory surgery centers that create and maintain vascular access for dialysis to operate as end stage renal disease service providers under New York law.

Why it matters

  1. Expands patient access to specialized vascular access procedures. by allowing ambulatory surgery centers to perform and maintain the critical vascular access needed for dialysis, potentially reducing wait times and travel for end stage renal disease (ESRD) patients.

  2. Enables more facilities to qualify as ESRD service providers,. which could increase the number of locations available for necessary surgical interventions, supporting continuity of care for dialysis patients.

  3. Maintains regulatory oversight and quality standards. by requiring these centers to demonstrate expertise in renal care and comply with existing rules on ownership, governance, and personnel qualifications, helping to ensure patient safety and care quality.

  4. Encourages innovation and investment in outpatient surgical care. for renal disease by clarifying that certain ambulatory surgery centers can legally operate as part of the ESRD care infrastructure, potentially attracting new providers and resources to the field.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Expand Kidney Care Centers

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Michael Gianaris

Senator · Senate District 12

1 Co-sponsor

History

  1. Referred to health
  2. Delivered to assembly
  3. Passed senateVote 61–0
  4. Advanced to third reading
  5. 2nd report cal.
  6. 1st report cal.987
  7. Referred to health
  8. Returned to senate
  9. Died in assembly
  10. Referred to health
  11. Delivered to assembly
  12. Passed senateVote 63–0
Show 2 earlier actions
  1. Ordered to third reading cal.1733
  2. Referred to rules

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A8080Assembly

Expand Kidney Disease Treatment

In Assembly Committee · Health · Sponsor Jeffrey Dinowitz

Impact 5 · Moderate0% to pass

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

7137

2021-2022 Regular Sessions

IN SENATE

June 2, 2021

Introduced by Sen. GIANARIS -- read twice and ordered printed, and when printed to be committed to the Committee on Rules

AN ACT to amend the public health law, in relation to the provision of end stage renal disease services

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Paragraph (a) of subdivision 15 of section 2801-a of the public health law, as amended by chapter 492 of the laws of 2011, is amended to read as follows:

(a) Diagnostic or treatment centers established exclusively to provide end stage renal disease services, including an ambulatory surgery center established exclusively to create and maintain vascular access necessary to dialyze patients with end stage renal disease, may be operated by corporations and limited liability companies formed under the laws of New York whose stockholders or members, as applicable, are not natural persons if such corporations and limited liability companies and its principal stockholders and members, as applicable, and controlling persons comply with all applicable requirements of this section and demonstrate, to the satisfaction of the public health and health planning council, sufficient experience and expertise in delivering high quality end stage renal disease care. For purposes of this subdivision, the public health and health planning council shall adopt and amend rules and regulations, notwithstanding any inconsistent provision of this section, to address any matter it deems pertinent to the establishment and operation of diagnostic or treatment centers pursuant to this subdivision; provided that such rules and regulations shall include, but not be limited to provisions governing or relating to: (i) any direct or indirect changes or transfers of ownership interests or voting rights in such corporations and limited liability companies or their stockholders or members, as applicable, and provide for public health and health planning council approval of any change in controlling interests, prin-

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD11761-01-1

S. 7137 2

cipal stockholders, principal members, controlling persons, parent company or sponsors; (ii) oversight of the operator and its stockholders or members, as applicable, including local governance of the diagnostic or treatment centers; and (iii) relating to the character and competence and qualifications of, and changes relating to, the directors, managers and officers of the operator and its principal stockholders, principal members, controlling persons, parent company or sponsors.

§ 2. This act shall take effect immediately.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the public health law, in relation to the provision of end stage renal disease services

Purpose

To clarify that diagnostic and treatment centers established exclusively to provide end stage renal disease services subject to Public Health Law § 2801-a (15)(a) includes ambulatory surgery centers established exclu- sively to create and maintain vascular access necessary to dialyze patients with end stage renal disease.

Summary of provisions

Section one amends paragraph (a) of subdivision 15 of section 2801-a of the public health law to add language that diagnostic and treatment centers established exclusively to provide end stage renal disease services includes ambulatory surgery centers established exclusively to create and maintain vascular access necessary to dialyze patients with end stage renal disease.

Section two sets the effective date.

Justification

Paragraph (a) of subdivision 15 of section 2801-a of the public health law authorizes diagnostic and treatment centers established exclusively to provide end stage renal disease services to be operated by corpo- rations and limited liability companies whose stockholders and members are not natural persons. Inasmuch as life-sustaining hemodialysis treat- ment necessarily depends upon the creation and maintenance of access to the patient's blood stream, end stage renal disease services necessarily includes the creation and maintenance of vascular access for end stage renal disease patients.

This bill will make clear that a diagnostic and treatment center estab- lished exclusively to provide end stage renal disease services includes an ambulatory surgery center established exclusively to create and main- tain vascular access for end stage renal disease patients receiving hemodialysis.

Clarification that dialysis corporations are authorized to establish single-specialty ambulatory surgery centers established exclusively to create and maintain vascular access for hemodialysis patients will facilitate the integration of dialysis treatment and dialysis vascular access. A vascular access integration model has been proven to (1) decrease catheter exposure time consistent with the Centers For Medicare and Medicaid Services (CMS) quality and cost containment goals, (2) increase the use of arteriovenous fistulas ("AVFs") as the preferred method of vascular access for hemodialysis consistent with CMS's Fistula First Initiative, with a concomitant decrease in costs and vascular complication rates, (3) decrease mortality rates, (4) decrease the number of missed dialysis treatments due to access compromise, (5) lower hospital admission rates and inpatient days consistent with DSRIP goals, and (6) decrease overall costs per ESRD patient.

Moreover, this Bill is consistent with CMS' ongoing efforts to reduce the cost, and manage the care of, ESRD patients as reflected in its Comprehensive ESRD Care ("CEC") Model and corresponding ESRD Seamless Care Organizations ("ESCOs") designed to coordinate all care for ESRD beneficiaries.

Legislative history

New bill.

Fiscal implications

None.

Local fiscal implications

EFFECTIVE DATE: Immediately.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.